Ilaria Catalano

Part of Merck & Co., Inc., MSD Italia Srl is a pharmaceutical company based in Rome, Italy. MSD Italia has been revolutionizing therapeutic paradigms for dozens of pathologies for over 60 years, and for 130 years worldwide, through the discovery of over 200 innovative molecules. The Italian company is committed to environmental sustainability and has set ambitious goals to meet the expectations of its customers, investors, external stakeholders, and employees. MSD Italia's innovation is 360 degrees, and its pipeline is one of the most promising, with about forty molecules in advanced stages of development. The company was founded in 1891. Nicoletta Luppi has been the CEO of the company since 2003.

Part of Merck & Co., Inc., MSD Italia Srl is a pharmaceutical company based in Rome, Italy. MSD Italia has been revolutionizing therapeutic paradigms for dozens of pathologies for over 60 years, and for 130 years worldwide, through the discovery of over 200 innovative molecules. The Italian company is committed to environmental sustainability and has set ambitious goals to meet the expectations of its customers, investors, external stakeholders, and employees. MSD Italia's innovation is 360 degrees, and its pipeline is one of the most promising, with about forty molecules in advanced stages of development. The company was founded in 1891. Nicoletta Luppi has been the CEO of the company since 2003.